Does TEMOZOLOMIDE Cause Neoplasm recurrence? 66 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 66 reports of Neoplasm recurrence have been filed in association with TEMOZOLOMIDE (TEMOZOLOMIDE). This represents 0.4% of all adverse event reports for TEMOZOLOMIDE.
66
Reports of Neoplasm recurrence with TEMOZOLOMIDE
0.4%
of all TEMOZOLOMIDE reports
10
Deaths
18
Hospitalizations
How Dangerous Is Neoplasm recurrence From TEMOZOLOMIDE?
Of the 66 reports, 10 (15.2%) resulted in death, 18 (27.3%) required hospitalization, and 1 (1.5%) were considered life-threatening.
Is Neoplasm recurrence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TEMOZOLOMIDE. However, 66 reports have been filed with the FAERS database.
What Other Side Effects Does TEMOZOLOMIDE Cause?
Disease progression (1,562)
Death (1,403)
Off label use (1,357)
Product use in unapproved indication (1,353)
Thrombocytopenia (1,300)
Drug ineffective (1,131)
Nausea (1,071)
Neutropenia (809)
Malignant neoplasm progression (779)
Fatigue (766)
What Other Drugs Cause Neoplasm recurrence?
CYCLOPHOSPHAMIDE (293)
PALBOCICLIB (248)
DOXORUBICIN (240)
VINCRISTINE (239)
CYTARABINE (223)
METHOTREXATE (198)
CARBOPLATIN (170)
RITUXIMAB (163)
ETOPOSIDE (156)
PREDNISONE (144)
Which TEMOZOLOMIDE Alternatives Have Lower Neoplasm recurrence Risk?
TEMOZOLOMIDE vs TEMSIROLIMUS
TEMOZOLOMIDE vs TENAMFETAMINE
TEMOZOLOMIDE vs TENAPANOR
TEMOZOLOMIDE vs TENECTEPLASE
TEMOZOLOMIDE vs TENELIGLIPTIN